The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Bone metastasis: mechanisms and therapeutic opportunities
Open accessAbstract
The skeleton is one of the most common sites for metastatic cancer, and tumors arising from the breast or prostate possess an increased propensity to spread to this site. The growth of disseminated tumor cells in the skeleton requires tumor cells to inhabit the bone marrow, from which they stimulate local bone cell activity. Crosstalk between tumor cells and resident bone and bone marrow cells disrupts normal bone homeostasis, which leads to tumor growth in bone. The metastatic tumor cells have the ability to elicit responses that stimulate bone resorption, bone formation or both. The net result of these activities is profound skeletal destruction that can have dire consequences for patients. The molecular mechanisms that underlie these painful and often incurable consequences of tumor metastasis to bone are beginning to be recognized, and they represent promising new molecular targets for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
The pathogenesis of cancer metastasis
Poste, G., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. (1987) · Science · doi:10.1126/science.3616618 · Cited by 1,293
Self-citationDenosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. M., Coblyn, J. S., Weinblatt, M. E., Massarotti, E. M., Remold-O’Donnell, E., Farndale, R. W., Ware, J., et al. (2010) · Science · doi:10.1126/science.1181928 · Cited by 1,085
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Self-citationGuise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
The Biology of Cancer Invasion and Metastasis
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60648-x · Cited by 801
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755
Massagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650
Beyond tumorigenesis: cancer stem cells in metastasis
Li, F., Tiede, B., Massagué, J., & Kang, Y. (2007) · Cell Research · doi:10.1038/sj.cr.7310118 · Cited by 620
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Guise, T. A., Mohammad, K. S., Clines, G., Stebbins, E. G., Wong, D. H., Higgins, L. S., Vessella, R., Corey, E., Padalecki, S., Suva, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1007 · Cited by 539
Self-citationFizazi, K., Lipton, A., Mariette, X., Body, J.-J., Rahim, Y., Gralow, J. R., Gao, G., Wu, L., Sohn, W., & Jun, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2146 · Cited by 533
Body, J.-J., Facon, T., Coleman, R. E., Lipton, A., Geurs, F., Fan, M., Holloway, D., Peterson, M. C., & Bekker, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1933 · Cited by 490
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/s8756-3282(02)00915-8 · Cited by 477
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 390
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J.-J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8604 · Cited by 389
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Immune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
Thalmann, G. N., Sikes, R. A., Wu, T. T., Degeorges, A., Chang, S.-M., Ozen, M., Pathak, S., & Chung, L. W. K. (2000) · The Prostate · doi:10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l · Cited by 366
The role of fibroblast growth factors and their receptors in prostate cancer
Kwabi-Addo, B., Ozen, M., & Ittmann, M. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00535 · Cited by 350
Acevedo, V. D., Gangula, R. D., Freeman, K. W., Li, R., Zhang, Y., Wang, F., Ayala, G. E., Peterson, L. E., Ittmann, M., & Spencer, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.004 · Cited by 308
The bone microenvironment in metastasis; what is special about bone?
Bussard, K. M., Gay, C. V., & Mastro, A. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9109-4 · Cited by 307
Prostate Cancer Cells Promote Osteoblastic Bone Metastases through Wnts
Hall, C. L., Bafico, A., Dai, J., Aaronson, S. A., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1317 · Cited by 303
Pathogenesis of myeloma bone disease
Roodman, G. D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22403 · Cited by 296
STEWART, A. F., VIGNERY, A., SILVERGLATE, A., RAVIN, N. D., LiVOLSI, V., BROADUS, A. E., & BARON, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-219 · Cited by 287
Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions
Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1787 · Cited by 278
Weitzmann, M. N., Cenci, S., Rifas, L., Brown, C., & Pacifici, R. (2000) · Blood · doi:10.1182/blood.v96.5.1873 · Cited by 265
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Bendre, M. S., Margulies, A. G., Walser, B., Akel, N. S., Bhattacharrya, S., Skinner, R. A., Swain, F., Ramani, V., Mohammad, K. S., Wessner, L. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2630 · Cited by 243
Self-citationMarkers of bone turnover for the management of patients with bone metastases from prostate cancer
Garnero, P., Buchs, N., Zekri, J., Rizzoli, R., Coleman, R. E., & Delmas, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1012 · Cited by 238
Vallet, S., Mukherjee, S., Vaghela, N., Hideshima, T., Fulciniti, M., Pozzi, S., Santo, L., Cirstea, D., Patel, K., Sohani, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911929107 · Cited by 230
Role of endothelin-1 in osteoblastic bone metastases
Guise, T. A., Yin, J. J., & Mohammad, K. S. (2003) · Cancer · doi:10.1002/cncr.11129 · Cited by 228
In Vivo Stimulation of Endosteal Bone Formation by Basic Fibroblast Growth Factor in Rats
Mayahara, H., Ito, T., Nagai, H., Miyajima, H., Tsukuda, R., Taketomi, S., Mizoguchi, J., & Kato, K. (1993) · Growth Factors · doi:10.3109/08977199308991583 · Cited by 220
Bailey, J. M., Singh, P. K., & Hollingsworth, M. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21509 · Cited by 209
Charhon, S. A., Chapuy, M. C., Delvin, E. E., Valentin-Opran, A., Edouard, C. M., & Meunier, P. J. (1983) · Cancer · doi:10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j · Cited by 208
Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201
Platelet glycoprotein Ibα supports experimental lung metastasis
Jain, S., Zuka, M., Liu, J., Russell, S., Dent, J., Guerrero, J. A., Forsyth, J., Maruszak, B., Gartner, T. K., Felding-Habermann, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700625104 · Cited by 197
Heparan sulfate proteoglycans and heparanase—partners in osteolytic tumor growth and metastasis
Sanderson, R. D., Yang, Y., Suva, L. J., & Kelly, T. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.08.004 · Cited by 189
Self-citationAdvances in the biology of bone metastasis: How the skeleton affects tumor behavior
Sterling, J. A., Edwards, J. R., Martin, T. J., & Mundy, G. R. (2011) · Bone · doi:10.1016/j.bone.2010.07.015 · Cited by 184
Mohammad, K. S., Chen, C. G., Balooch, G., Stebbins, E., McKenna, C. R., Davis, H., Niewolna, M., Peng, X. H., Nguyen, D. H. N., Ionova-Martin, S. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005275 · Cited by 179
Self-citationDickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation
Clines, G. A., Mohammad, K. S., Bao, Y., Stephens, O. W., Suva, L. J., Shaughnessy, J. D., Fox, J. W., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0346 · Cited by 179
Self-citationKang, H., Watkins, G., Parr, C., Douglas-Jones, A., Mansel, R. E., & Jiang, W. G. (2005) · Breast Cancer Research · doi:10.1186/bcr1022 · Cited by 178
Yi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases
Roudier, M. P., Morrissey, C., True, L. D., Higano, C. S., Vessella, R. L., & Ott, S. M. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.04.140 · Cited by 166
Pathogenesis of myeloma bone disease
Roodman, G. (2004) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.01.001 · Cited by 163
Monocyte Chemotactic Protein-1 Mediates Prostate Cancer–Induced Bone Resorption
Lu, Y., Cai, Z., Xiao, G., Keller, E. T., Mizokami, A., Yao, Z., Roodman, G. D., & Zhang, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1210 · Cited by 162
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J. J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5234 · Cited by 162
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Adaptation versus Selection: The Origins of Metastatic Behavior
Scheel, C., Önder, T. T., Karnoub, A. E., & Weinberg, R. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1653 · Cited by 158
Physiology and Pharmacology of Bone
Mundy, G. R., & Martin, T. J. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6 · Cited by 154
The critical role of the bone microenvironment in cancer metastases
Casimiro, S., Guise, T. A., & Chirgwin, J. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.004 · Cited by 154
Dynamic Heterogeneity: Rapid Generation of Metastatic Variants in Mouse B16 Melanoma Cells
Hill, R. P., Chambers, A. F., Ling, V. W. T., & Harris, J. F. (1984) · Science · doi:10.1126/science.6719130 · Cited by 153
Harris, S. E., Harris, M. A., Mahy, P., Feng, J. Q., Mundy, G. R., & Wozney, J. M. (1994) · The Prostate · doi:10.1002/pros.2990240406 · Cited by 144
RANK ligand as a therapeutic target for bone metastases and multiple myeloma
Roodman, G. D., & Dougall, W. C. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.09.002 · Cited by 142
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang, Y., MacLeod, V., Dai, Y., Khotskaya-Sample, Y., Shriver, Z. H., Venkataraman, G., Sasisekharan, R., Naggi, A., Torri, G., Casu, B., et al. (2007) · Blood · doi:10.1182/blood-2007-04-082495 · Cited by 133
Self-citationBiochemical markers of bone turnover in patients with metastatic bone disease
DEMERS, L. M., Costa, L., Chinchilli, V. M., Gaydos, L. J., Curley, E., & Lipton, A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1489 · Cited by 133
Clonal Selection of Metastasis within the Life History of a Tumor
Talmadge, J. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2496 · Cited by 131
Mechanisms of bone metastases of breast cancer
Suva, L. J., Griffin, R. J., & Makhoul, I. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0012 · Cited by 131
Self-citationParathyroid Hormone–Related Protein Localization in Breast Cancers Predict Improved Prognosis
Henderson, M. A., Danks, J. A., Slavin, J., Byrnes, G. B., Choong, P., Spillane, J. B., Hopper, J. L., & Martin, T. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2814 · Cited by 128
Coleman, R. E., Brown, J. E., Terpos, E., Lipton, A., Smith, M. R., Cook, R. J., & Major, P. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.05.001 · Cited by 124
Dunstan, C. R., Boyce, R. W., Boyce, B. F., Garrett, I. R., Izbicka, E., Burgess, W. H., & Mundy, G. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.953 · Cited by 124
Percival, R. C., Urwin, G. H., Harris, S., Yates, A. J. P., Williams, J. L., Beneton, M. N. C., & Kanis, J. A. (1987) · PubMed · Cited by 124
Breast Cancer Metastasis to Bone
Bendre, M. S., Gaddy, D., Nicholas, R. W., & Suva, L. J. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093844.72468.f4 · Cited by 122
Self-citationInfluence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer
Feeley, B. T., Gamradt, S. C., Hsu, W. K., Liu, N., Krenek, L., Robbins, P., Huard, J., & Lieberman, J. R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050802 · Cited by 120
Kelly, T. J., Suva, L. J., Huang, Y., MacLeod, V., Miao, H., Walker, R. C., & Sanderson, R. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0749 · Cited by 105
Self-citationBone morphogenetic protein signaling in prostate cancer cell lines
Brubaker, K. D., Corey, E., Brown, L. G., & Vessella, R. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10679 · Cited by 104
Kim, I. Y., Lee, D. H., Ahn, H. J., Tokunaga, H., Song, W., Devereaux, L., Jin, D. F., Sampath, T. K., & Morton, R. A. (2000) · PubMed · Cited by 102
Lau, Y. S., Danks, L., Sun, S. G., Fox, S. B., Sabokbar, A., Harris, A. L., & Athanasou, N. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9438-y · Cited by 101
Vij, R., Horvath, N., Spencer, A. G., Taylor, K., Vadhan‐Raj, S., Vescio, R. A., Smith, J. W. G., Qian, Y., Yeh, H., & Jun, S. (2009) · American Journal of Hematology · doi:10.1002/ajh.21509 · Cited by 99
The role of Wnts in bone metastases
Hall, C. L., & Keller, E. T. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9022-2 · Cited by 91
Arya, M., Ahmed, H. U., Silhi, N., Williamson, M. P., & Patel, H. (2007) · Tumor Biology · doi:10.1159/000102979 · Cited by 84
Suva, L. J., Hartman, E., Dilley, J. D., Russell, S., Akel, N. S., Skinner, R. A., Hogue, W. R., Budde, U., Varughese, K. I., Kanaji, T., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070417 · Cited by 75
Self-citationPelger, R. C. M., Hamdy, N. A. T., Zwinderman, A. H., Nijeholt, A. A. B. L. À., & Papapoulos, S. E. (1998) · Bone · doi:10.1016/s8756-3282(97)00289-5 · Cited by 75
LeRoy, B. E., Thudi, N. K., Nadella, M. V. P., Toribio, R. E., Tannehill‐Gregg, S. H., van Bokhoven, A., Davis, D., Corn, S. C., & Rosol, T. J. (2006) · The Prostate · doi:10.1002/pros.20408 · Cited by 74
Morrissey, C. M., Brown, L. G., Pitts, T. E. M., Vessella, R. L., & Corey, E. (2010) · Neoplasia · doi:10.1593/neo.91836 · Cited by 74
Amano, H., Ito, Y., Suzuki, T., Kato, S., Matsui, Y., Ogawa, F., Murata, T., Sugimoto, Y., Senior, R. M., Kitasato, H., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01322.x · Cited by 71
Vessella, R. L., & Corey, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0813 · Cited by 71
Kodama, N., Nagata, M., Tabata, Y., Ozeki, M., Ninomiya, T., & Takagi, R. (2009) · Bone · doi:10.1016/j.bone.2008.12.017 · Cited by 63
Fili, S., Karalaki, M., & Schaller, B. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.011 · Cited by 63
Coleman, R. E. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.022 · Cited by 63
Regulation of bone mass by mechanical loading: Microarchitecture and genetics
Suva, L. J., Gaddy, D., Perrien, D. S., Thomas, R. L., & Findlay, D. M. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0003-0 · Cited by 62
Self-citationNew insights into the role of T cells in the vicious cycle of bone metastases
Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231909.35043.da · Cited by 60
A novel model of bone‐metastatic prostate cancer in immunocompetent Mice
Power, C. A., Pwint, H., Chan, J. C. H., Cho, J., Yu, Y. Y., Walsh, W. R., & Russell, P. J. (2009) · The Prostate · doi:10.1002/pros.21010 · Cited by 56
Ye, L., Lewis-Russell, J. M., Kynaston, H., & Jiang, W. G. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.05.003 · Cited by 55
Novel Bone-Targeted Strategies in Oncology
Vallet, S., Smith, M. R., & Raje, N. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0600 · Cited by 44
Angiogenesis in the Bone Marrow of Patients with Breast Cancer
Chávez‐MacGregor, M., Avilés‐Salas, A., Green, D., Fuentes‐Alburo, A., Gómez-Ruíz, C., & Aguayo, Á. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2420 · Cited by 43
Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
Kelly, T. J., Suva, L. J., Nicks, K. M., MacLeod, V., & Sanderson, R. D. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.16 · Cited by 42
Self-citationManipulating the environment of cancer cells in bone: a novel therapeutic approach
Martin, T. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0217124 · Cited by 40
Sant, C. V., Wang, G., Anderson, M. G., Trask, O. J., Lesniewski, R., & Semizarov, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0574 · Cited by 38
Stokkel, M. P. M., Linthorst, M., Borm, J. J. J., Taminiau, A., & Pauwels, E. J. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0350-5 · Cited by 36
Pathophysiology of Skeletal Complications of Cancer
Mundy, G. R., & Martin, T. J. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_18 · Cited by 31
Metastasizing potentials of mouse mammary tumors and their metastases
Vaage, J. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410614 · Cited by 31
Pennisi, A., Li, X., Ling, W., Khan, S., Gaddy, D., Suva, L. J., Barlogie, B., Shaughnessy, J. D., Aziz, N., & Yaccoby, S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07696.x · Cited by 28
Self-citationCárcel‐Trullols, J., Stanley, J. S., Saha, R., Shaaf, S., Bendre, M. S., Monzavi‐Karbassi, B., Suva, L. J., & Kieber‐Emmons, T. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1173 · Cited by 25
Self-citationJia, D., Koonce, N. A., Halakatti, R., Li, X., Yaccoby, S., Swain, F. L., Suva, L. J., Hennings, L. J., Berridge, M. S., Apana, S. M., et al. (2010) · Radiation Research · doi:10.1667/rr1734.1 · Cited by 14
Self-citation
Cited by
Huang, Z., Chu, L., Liang, J., Tan, X., Wang, Y., Wen, J., Chen, J., Wu, Y., Liu, S., Liao, J., et al. (2021) · Hepatology · doi:10.1002/hep.31673 · Cited by 82
Yang, C., Davis, J. L., Zeng, R., Vora, P., Su, X., Collins, L. I., Vangveravong, S., Mach, R. H., Piwnica-Worms, D., Weilbaecher, K. N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0271 · Cited by 50
Zhang, Y., Wang, Y., Zhu, A., Yu, N., Xia, J., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202310252 · Cited by 43
Bone metastases from hepatocellular carcinoma: clinical features and prognostic factors
Lu, Y., Hu, J.-G., Lin, X.-J., & Li, X.-G. (2017) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(16)60173-x · Cited by 26
Metadata
- Authors
- Suva, L. J., Washam, C., Nicholas, R. W., & Griffin, R. J.
- Venue
- Nature Reviews Endocrinology
- Published
- 2011-01-04
- Volume
- 7
- Issue
- 4
- Pages
- 208-218
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2158903927
- Cited by
- 424
- References
- 117
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.